Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 Hi , I'm a mother of 4, diagnosed with cml at 22 weeks of pregnancy with my youngest child, now 7 months old. I'm on this cml boat without buying a ticket for it. Since when we all have to think on the same lines? I thought that was the idea of freedom of speech; actual ability to raise ones opinions. I clearly stated this is my belief. I also believed in myself when I decided to have my baby at home by myself (no medical assistance) despite doctors not giving me a green light for home birth. Mind is extremely powerful organ and we can at least try to control it a bit. I know myself and I know I DID cause my illness, just getting out of it proved to be a challenge. Now, if you think I made illiterate, untrue and selfish statement, please prove it to me if you dare. From: hey00nanc Sent: Saturday, October 02, 2010 11:21 PM Subject: Re: [ ] Breast feeding while on Gleevec > > who r u to make such a strong untrue selfish illiterate statement? That is totally out of line! > Sent via BlackBerry by AT & T _____________________________ Remember that this is the same list-mate who recently wrote her opinion that we create our own diseases (cancers) and that those who are not successful with treatment have a wish to die prematurely! someone honestly said that. Just because you believe something, that does not mean that it is true! it is just something that You believe. C. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 Unfortunately I'm on the same boat as any other member of this group but not on the same page, or rather not even in the same book. If you think it was or is easy for me to be diagnosed with cml at 22 weeks of my last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7 months you got it all wrong. At least most of you have mature families with some grandchildren, something I may not experience my self so I'm making the most of what I've got now. The hell with it! From: onthewtr@... Sent: Saturday, October 02, 2010 10:19 PM Subject: Re: [ ] Breast feeding while on Gleevec who r u to make such a strong untrue selfish illiterate statement? That is totally out of line! Sent via BlackBerry by AT & T [ ] Breast feeding while on Gleevec I am gravely concerned about a member who posted recently that she was breast feeding her baby while on Gleevec. I want her to know that I am not judging her, but merely reiterating what has been passed down to us repeately. In speaking directly to her, I hope you have permission, dear member from your doctor or you could be playing Russian roulette with your baby's health. This is the warning that comes with Gleevec. Women who want to become pregnant should not do so while taking Gleevec or any other TKI. If you need further proof, I urge you to please contact the Novartis Hotline or the instructions that comes in your package. This comes from their webpage: Who should NOT take GLEEVEC Women who are or could be pregnant. Fetal harm can occur when administered to pregnant women; therefore, women should not become pregnant, as well as be advised of the potential risk to the unborn child if GLEEVEC is used during pregnancy. " Women who are breast-feeding because of the potential for serious adverse reactions in nursing infants. " Sexually active females should use adequate birth control while taking GLEEVEC. " Be sure to talk to your doctor and/or healthcare professional about these issues before taking GLEEVEC " http://tinyurl.com/29fl97v --_________________ I further give you warnings from the following information published in the Internet Journal of Oncology. This article was written by Ault MS, RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner School of Nursing The University of Texas Health Science Center at Houston and I quote from her article (noted in 2010 Volume 7 Number 2). I have known Pat Ault for a long time, also most of the doctors in that department. She would not have been given permission to write this article without the blessings of the doctors at MDACC that she works under and I respect her authority on the subject of CML. You will note that everything I copied is in " quotations " . Some quotes I have excerpted are posted here, but the entire article can be seen at the recited website listed below the quotes, however, it is very lengthy: " Management of CML during pregnancy poses challenges to both hematologists and obstetricians. Currently, consensus is lacking in management of CML in pregnancy; therefore, clinical observations have become important. Most of these observations are derived from small case series or case reports. " Therefore, leukapheresis may be an intermittent short-term alternative option for pregnant patients, and prevents fetal exposure to TERATOGENIC drugs. However, leukapheresis is cumbersome, costly, and a time consuming procedure, with risk of infection, thrombosis and hypotensive events that may affect the fetus and patient. " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. " Investigation of the placentas included standard pathologic analysis, computer assisted morphometry, and fluorescence in situ hybridization (FISH) analysis. This patient was treated with a targeted tyrosine inhibitor during first trimester of a first pregnancy and during the third trimester of a second pregnancy. The umbilical cord blood and breast milk findings were: 1) low imatinib and metabolite concentration levels found in the umbilical blood suggest limited placental transfer in late pregnancy, and 2) HIGH CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST MILK. " Rousselot et al (2007) reported imatinib may be discontinued in patients who achieved a complete molecular remission for a period of at least 2 years without evidence of disease progression. " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); considering this milk intake and the infants are unlikely to receive more than 3 mg/d imatinib daily. This amount is far from therapeutic range, therefore, concluding that mothers with CML could safely breast-feed the infant. However, the effects of low-dose chronic exposure of infants to imatinib are not known, and have not undergone long-term investigation; THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. ttp://tinyurl.com/2g82tpc FYI, Lottie Duthu Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 Sorry anna I thought I signed my name. Research does state that mothers shouldn't breastfeed and furthermore what I wrote is not from emotional distress. From the posts everyone is in agreement that your statement about if mothers don't breastfeed they are poor excuse for a mother was illerate hurtful and insensetive. Literature from md anderson states that it is possible gleevec passes through the mothers milk but I guess you are smarter then them. The website on gleevec states this also. But it was your decision to breastfeed and that was your business but to make a statement about mothers being poor excuses for mothers not breastfeeding was way out of line Everything I typed was in my own words so that really didn't make much sense on your part Regards Penny Sent from my Verizon Wireless BlackBerry Re: [ ] Breast feeding while on Gleevec > > I agree Zavie. while I don't post much about CML anymore I am concerned with the absurd theory that if you don't breastfeed you are a bad mother. My own daughter who just recently gave birth did not make milk for health reasons and she is a wonderful Mom. Which is worse, no breast or a Mom who can't admit she isn't making enough milk to sustain her child? I believe I was on the evaporated milk and karo diet and survived because of a great mom. Everyday at school I help care for children who were breastfed and now have autism, learning disabilities etc. Moms who have this bad attitude certainly will not foster caring children as they grow. Sorry if I hurt anyone but I feel many young mothers who have to make the decision not to breastfeed are being given a very bad rap! Lynn F > [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 first of all that was me not making that statement. I just read all of your posts and yes you are entitled to freedom of speech but I do not believe that you have to be so hurtful in what you say--saying that a mother that does nurse is a bad mother is not very kind and you have no proof of that so why say it. And another thing. you keep referring to most of us being old? how do you know that? Being old makes us wiser and maybe you should listen to some of us older ones -=we are older and wiser!!! I am sure you have heard from many young mothers--not just old people like us!. Sharon _____ From: [mailto: ] On Behalf Of d'Araille Sent: Sunday, October 03, 2010 6:55 AM Subject: Re: [ ] Breast feeding while on Gleevec Hi , I'm a mother of 4, diagnosed with cml at 22 weeks of pregnancy with my youngest child, now 7 months old. I'm on this cml boat without buying a ticket for it. Since when we all have to think on the same lines? I thought that was the idea of freedom of speech; actual ability to raise ones opinions. I clearly stated this is my belief. I also believed in myself when I decided to have my baby at home by myself (no medical assistance) despite doctors not giving me a green light for home birth. Mind is extremely powerful organ and we can at least try to control it a bit. I know myself and I know I DID cause my illness, just getting out of it proved to be a challenge. Now, if you think I made illiterate, untrue and selfish statement, please prove it to me if you dare. From: hey00nanc Sent: Saturday, October 02, 2010 11:21 PM <mailto:%40> Subject: Re: [ ] Breast feeding while on Gleevec --- In <mailto:%40> , onthewtr@... wrote: > > who r u to make such a strong untrue selfish illiterate statement? That is totally out of line! > Sent via BlackBerry by AT & T _____________________________ Remember that this is the same list-mate who recently wrote her opinion that we create our own diseases (cancers) and that those who are not successful with treatment have a wish to die prematurely! someone honestly said that. Just because you believe something, that does not mean that it is true! it is just something that You believe. C. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 typo--i meant to say mother that does not nurse!!! Sharon _____ From: [mailto: ] On Behalf Of Sharon Teichera Sent: Sunday, October 03, 2010 7:35 AM Subject: RE: [ ] Breast feeding while on Gleevec first of all that was me not making that statement. I just read all of your posts and yes you are entitled to freedom of speech but I do not believe that you have to be so hurtful in what you say--saying that a mother that does nurse is a bad mother is not very kind and you have no proof of that so why say it. And another thing. you keep referring to most of us being old? how do you know that? Being old makes us wiser and maybe you should listen to some of us older ones -=we are older and wiser!!! I am sure you have heard from many young mothers--not just old people like us!. Sharon _____ From: <mailto:%40> [mailto: <mailto:%40> ] On Behalf Of d'Araille Sent: Sunday, October 03, 2010 6:55 AM <mailto:%40> Subject: Re: [ ] Breast feeding while on Gleevec Hi , I'm a mother of 4, diagnosed with cml at 22 weeks of pregnancy with my youngest child, now 7 months old. I'm on this cml boat without buying a ticket for it. Since when we all have to think on the same lines? I thought that was the idea of freedom of speech; actual ability to raise ones opinions. I clearly stated this is my belief. I also believed in myself when I decided to have my baby at home by myself (no medical assistance) despite doctors not giving me a green light for home birth. Mind is extremely powerful organ and we can at least try to control it a bit. I know myself and I know I DID cause my illness, just getting out of it proved to be a challenge. Now, if you think I made illiterate, untrue and selfish statement, please prove it to me if you dare. From: hey00nanc Sent: Saturday, October 02, 2010 11:21 PM <mailto:%40> <mailto:%40> Subject: Re: [ ] Breast feeding while on Gleevec --- In <mailto:%40> <mailto:%40> , onthewtr@... wrote: > > who r u to make such a strong untrue selfish illiterate statement? That is totally out of line! > Sent via BlackBerry by AT & T _____________________________ Remember that this is the same list-mate who recently wrote her opinion that we create our own diseases (cancers) and that those who are not successful with treatment have a wish to die prematurely! someone honestly said that. Just because you believe something, that does not mean that it is true! it is just something that You believe. C. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 , I don't often post, I have trouble on with certain of my computers but I borrowed my friend's Mac because this is not a time for silence. First let me say that I'm sorry you feel that you don't belong in the group. Of course you belong, you have CML. But that is in many cases the only common thread that connects us. Yet we become friends and in many cases family. Who else can really understand the path we walk? Friendships are formed here but even in the greatest of friendships there may be disagreements. It appears this is one such time. You are correct when you say breast feeding is good for children. You are correct when you say, it is your decision to continue to breast feed. I think the issue began when you stated that anyone who did not breast feed is a bad mother. We have enough struggles with our disease without judging each other and to paint us as bad mothers is hurtful. It appears from your post that you did your research but all the journals in the world cannot predict the future. You say that you are young, then perhaps you are not aware of the drugs that did not impact the mothers but did give the daughters cancer as young women. As parents we are charged to do what is right for our children. We make decisions everyday which hopefully are centered on the needs of the child; not our own. We are lucky that CML in chronic phase is slow moving. I probably had it for almost two years before diagnosis. While I drink green tea daily and have for about 15 years, I think and it is just my opinion, that you were able to carry your baby to term and remain off meds due to the slow progression which is the hallmark of the disease in chronic phase. The story may have had a different ending if you were in blast phase at diagnosis. I'm not arguing with you, I have no need to be right. I just want you to consider other view points when you are making your decisions. I can tell you are a loving and caring mother. I guess that this discussion is rendered moot by your statement that you are pretty much dried up and now just breast feed for comfort. Even as non-scientist we have to believe that something that can affect us at a genetic level, as Gleevec does, has to be some pretty strong stuff. You wouldn't take a spoon and feed her a little bit of poison, even 10%. You state how much you love breast feeding, please consider whose needs and comfort are being met, if in fact there is no nutritional value and there may even be harm. I hope you will stay as a member. I'm sorry if you felt attacked but from where I sit you lobbed the first round- with the bad mother comment. We all are connected by our disease. But we can't leave our manners at the door. Are you aware that we have Skip who has had CML for over 30 years? Or that many of the people on this list were in the clinical trials for the very medicine that is keeping you alive? We are fortunate to have a living history of the fight against this disease. They have so much knowledge. Please stay and benefit from this knowledge. One final piece of information if you were in the US, your doctor would probably have reported you for child endangerment based on all of the warnings documented by Novartis. I have no judgement on what kind of a mother you are ; I hope you will extend the same courtesy to the rest of us - we do the best we can and when we know better, the hope is that we will do better. I know I try to do better everyday. China ________________________________ From: d'Araille <darajek@...> Sent: Sun, October 3, 2010 7:10:37 AM Subject: Re: [ ] Breast feeding while on Gleevec Unfortunately I'm on the same boat as any other member of this group but not on the same page, or rather not even in the same book. If you think it was or is easy for me to be diagnosed with cml at 22 weeks of my last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7 months you got it all wrong. At least most of you have mature families with some grandchildren, something I may not experience my self so I'm making the most of what I've got now. The hell with it! From: onthewtr@... Sent: Saturday, October 02, 2010 10:19 PM Subject: Re: [ ] Breast feeding while on Gleevec who r u to make such a strong untrue selfish illiterate statement? That is totally out of line! Sent via BlackBerry by AT & T [ ] Breast feeding while on Gleevec I am gravely concerned about a member who posted recently that she was breast feeding her baby while on Gleevec. I want her to know that I am not judging her, but merely reiterating what has been passed down to us repeately. In speaking directly to her, I hope you have permission, dear member from your doctor or you could be playing Russian roulette with your baby's health. This is the warning that comes with Gleevec. Women who want to become pregnant should not do so while taking Gleevec or any other TKI. If you need further proof, I urge you to please contact the Novartis Hotline or the instructions that comes in your package. This comes from their webpage: Who should NOT take GLEEVEC Women who are or could be pregnant. Fetal harm can occur when administered to pregnant women; therefore, women should not become pregnant, as well as be advised of the potential risk to the unborn child if GLEEVEC is used during pregnancy. " Women who are breast-feeding because of the potential for serious adverse reactions in nursing infants. " Sexually active females should use adequate birth control while taking GLEEVEC. " Be sure to talk to your doctor and/or healthcare professional about these issues before taking GLEEVEC " http://tinyurl.com/29fl97v --_________________ I further give you warnings from the following information published in the Internet Journal of Oncology. This article was written by Ault MS, RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner School of Nursing The University of Texas Health Science Center at Houston and I quote from her article (noted in 2010 Volume 7 Number 2). I have known Pat Ault for a long time, also most of the doctors in that department. She would not have been given permission to write this article without the blessings of the doctors at MDACC that she works under and I respect her authority on the subject of CML. You will note that everything I copied is in " quotations " . Some quotes I have excerpted are posted here, but the entire article can be seen at the recited website listed below the quotes, however, it is very lengthy: " Management of CML during pregnancy poses challenges to both hematologists and obstetricians. Currently, consensus is lacking in management of CML in pregnancy; therefore, clinical observations have become important. Most of these observations are derived from small case series or case reports. " Therefore, leukapheresis may be an intermittent short-term alternative option for pregnant patients, and prevents fetal exposure to TERATOGENIC drugs. However, leukapheresis is cumbersome, costly, and a time consuming procedure, with risk of infection, thrombosis and hypotensive events that may affect the fetus and patient. " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. " Investigation of the placentas included standard pathologic analysis, computer assisted morphometry, and fluorescence in situ hybridization (FISH) analysis. This patient was treated with a targeted tyrosine inhibitor during first trimester of a first pregnancy and during the third trimester of a second pregnancy. The umbilical cord blood and breast milk findings were: 1) low imatinib and metabolite concentration levels found in the umbilical blood suggest limited placental transfer in late pregnancy, and 2) HIGH CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST MILK. " Rousselot et al (2007) reported imatinib may be discontinued in patients who achieved a complete molecular remission for a period of at least 2 years without evidence of disease progression. " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); considering this milk intake and the infants are unlikely to receive more than 3 mg/d imatinib daily. This amount is far from therapeutic range, therefore, concluding that mothers with CML could safely breast-feed the infant. However, the effects of low-dose chronic exposure of infants to imatinib are not known, and have not undergone long-term investigation; THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. ttp://tinyurl.com/2g82tpc FYI, Lottie Duthu Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 I am 38 and have been here since age 33. Mother of 3 children (14,11,9). In a message dated 10/3/2010 4:43:00 P.M. Central Daylight Time, formiga101@... writes: I am 29 and have been part of this group almost 7 years From: _ryan.romero@..._ (mailto:ryan.romero@...) <_ryan.romero@..._ (mailto:ryan.romero@...) > Subject: Re: [ ] Breast feeding while on Gleevec _ _ (mailto: ) Date: Sunday, October 3, 2010, 1:13 PM I'm 28 Thanks [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > _http://tinyurl.com/29fl97v_ (http://tinyurl.com/29fl97v) > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > _ttp://tinyurl.com/2g82tpc_ (ttp://tinyurl.com/2g82tpc) > > FYI, > > Lottie Duthu > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > > > > > > > [Non-text portions of this message have been removed] > [Non-text portions of this message have been removed] [Non-text portions of this message have been removed] [Non-text portions of this message have been removed] Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 I'm done with this group. It should be called CML-support offered to over 60's only, no baby related subjects allowed. > > , > > I don't often post, I have trouble on with certain of my computers but I > borrowed my friend's Mac because this is not a time for silence. First let me > say that I'm sorry you feel that you don't belong in the group. Of course you > belong, you have CML. But that is in many cases the only common thread that > connects us. Yet we become friends and in many cases family. Who else can > really understand the path we walk? Friendships are formed here but even in the > greatest of friendships there may be disagreements. It appears this is one such > time. > > You are correct when you say breast feeding is good for children. You are > correct when you say, it is your decision to continue to breast feed. I think > the issue began when you stated that anyone who did not breast feed is a bad > mother. > > We have enough struggles with our disease without judging each other and to > paint us as bad mothers is hurtful. > > It appears from your post that you did your research but all the journals in > the world cannot predict the future. You say that you are young, then perhaps > you are not aware of the drugs that did not impact the mothers but did give the > daughters cancer as young women. As parents we are charged to do what is right > for our children. We make decisions everyday which hopefully are centered on > the needs of the child; not our own. > > We are lucky that CML in chronic phase is slow moving. I probably had it for > almost two years before diagnosis. While I drink green tea daily and have for > about 15 years, I think and it is just my opinion, that you were able to carry > your baby to term and remain off meds due to the slow progression which is the > hallmark of the disease in chronic phase. The story may have had a different > ending if you were in blast phase at diagnosis. I'm not arguing with you, I have > no need to be right. I just want you to consider other view points when you are > making your decisions. > > I can tell you are a loving and caring mother. I guess that this discussion is > rendered moot by your statement that you are pretty much dried up and now just > breast feed for comfort. Even as non-scientist we have to believe that something > that can affect us at a genetic level, as Gleevec does, has to be some pretty > strong stuff. You wouldn't take a spoon and feed her a little bit of poison, > even 10%. You state how much you love breast feeding, please consider whose > needs and comfort are being met, if in fact there is no nutritional value and > there may even be harm. > > I hope you will stay as a member. I'm sorry if you felt attacked but from where > I sit you lobbed the first round- with the bad mother comment. We all are > connected by our disease. But we can't leave our manners at the door. Are you > aware that we have Skip who has had CML for over 30 years? Or that many of the > people on this list were in the clinical trials for the very medicine that is > keeping you alive? We are fortunate to have a living history of the fight > against this disease. They have so much knowledge. Please stay and benefit > from this knowledge. > > One final piece of information if you were in the US, your doctor would probably > have reported you for child endangerment based on all of the warnings documented > by Novartis. > > I have no judgement on what kind of a mother you are ; I hope you will extend > the same courtesy to the rest of us - we do the best we can and when we know > better, the hope is that we will do better. I know I try to do better everyday. > > China > > > > ________________________________ > From: d'Araille <darajek@...> > > Sent: Sun, October 3, 2010 7:10:37 AM > Subject: Re: [ ] Breast feeding while on Gleevec > > > Unfortunately I'm on the same boat as any other member of this group but not on > the same page, or rather not even in the same book. > If you think it was or is easy for me to be diagnosed with cml at 22 weeks of my > last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7 months > you got it all wrong. > At least most of you have mature families with some grandchildren, something I > may not experience my self so I'm making the most of what I've got now. > The hell with it! > > > From: onthewtr@... > Sent: Saturday, October 02, 2010 10:19 PM > > Subject: Re: [ ] Breast feeding while on Gleevec > > who r u to make such a strong untrue selfish illiterate statement? That is > totally out of line! > > Sent via BlackBerry by AT & T > > [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 I agree with the baby subject however, I am 30 and get a lot of useful information from everyone that posts on here! Thanks, Sent from my Verizon Wireless BlackBerry [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 i do not believe that all of us are over 60--help someone-speak up!!!! _____ From: [mailto: ] On Behalf Of Mumminki Sent: Sunday, October 03, 2010 12:18 PM Subject: Re: [ ] Breast feeding while on Gleevec I'm done with this group. It should be called CML-support offered to over 60's only, no baby related subjects allowed. > > , > > I don't often post, I have trouble on with certain of my computers but I > borrowed my friend's Mac because this is not a time for silence. First let me > say that I'm sorry you feel that you don't belong in the group. Of course you > belong, you have CML. But that is in many cases the only common thread that > connects us. Yet we become friends and in many cases family. Who else can > really understand the path we walk? Friendships are formed here but even in the > greatest of friendships there may be disagreements. It appears this is one such > time. > > You are correct when you say breast feeding is good for children. You are > correct when you say, it is your decision to continue to breast feed. I think > the issue began when you stated that anyone who did not breast feed is a bad > mother. > > We have enough struggles with our disease without judging each other and to > paint us as bad mothers is hurtful. > > It appears from your post that you did your research but all the journals in > the world cannot predict the future. You say that you are young, then perhaps > you are not aware of the drugs that did not impact the mothers but did give the > daughters cancer as young women. As parents we are charged to do what is right > for our children. We make decisions everyday which hopefully are centered on > the needs of the child; not our own. > > We are lucky that CML in chronic phase is slow moving. I probably had it for > almost two years before diagnosis. While I drink green tea daily and have for > about 15 years, I think and it is just my opinion, that you were able to carry > your baby to term and remain off meds due to the slow progression which is the > hallmark of the disease in chronic phase. The story may have had a different > ending if you were in blast phase at diagnosis. I'm not arguing with you, I have > no need to be right. I just want you to consider other view points when you are > making your decisions. > > I can tell you are a loving and caring mother. I guess that this discussion is > rendered moot by your statement that you are pretty much dried up and now just > breast feed for comfort. Even as non-scientist we have to believe that something > that can affect us at a genetic level, as Gleevec does, has to be some pretty > strong stuff. You wouldn't take a spoon and feed her a little bit of poison, > even 10%. You state how much you love breast feeding, please consider whose > needs and comfort are being met, if in fact there is no nutritional value and > there may even be harm. > > I hope you will stay as a member. I'm sorry if you felt attacked but from where > I sit you lobbed the first round- with the bad mother comment. We all are > connected by our disease. But we can't leave our manners at the door. Are you > aware that we have Skip who has had CML for over 30 years? Or that many of the > people on this list were in the clinical trials for the very medicine that is > keeping you alive? We are fortunate to have a living history of the fight > against this disease. They have so much knowledge. Please stay and benefit > from this knowledge. > > One final piece of information if you were in the US, your doctor would probably > have reported you for child endangerment based on all of the warnings documented > by Novartis. > > I have no judgement on what kind of a mother you are ; I hope you will extend > the same courtesy to the rest of us - we do the best we can and when we know > better, the hope is that we will do better. I know I try to do better everyday. > > China > > > > ________________________________ > From: d'Araille <darajek@...> > <mailto:%40> > Sent: Sun, October 3, 2010 7:10:37 AM > Subject: Re: [ ] Breast feeding while on Gleevec > > > Unfortunately I'm on the same boat as any other member of this group but not on > the same page, or rather not even in the same book. > If you think it was or is easy for me to be diagnosed with cml at 22 weeks of my > last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7 months > you got it all wrong. > At least most of you have mature families with some grandchildren, something I > may not experience my self so I'm making the most of what I've got now. > The hell with it! > > > From: onthewtr@... > Sent: Saturday, October 02, 2010 10:19 PM > <mailto:%40> > Subject: Re: [ ] Breast feeding while on Gleevec > > who r u to make such a strong untrue selfish illiterate statement? That is > totally out of line! > > Sent via BlackBerry by AT & T > > [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 thank you Sharon _____ From: [mailto: ] On Behalf Of rnmichelle80@... Sent: Sunday, October 03, 2010 12:43 PM Subject: Re: [ ] Breast feeding while on Gleevec I agree with the baby subject however, I am 30 and get a lot of useful information from everyone that posts on here! Thanks, Sent from my Verizon Wireless BlackBerry [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 I'm 28 Thanks [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 I am 29 and have been part of this group almost 7 years --- On Sun, 10/3/10, ryan.romero@... <ryan.romero@...> wrote: From: ryan.romero@... <ryan.romero@...> Subject: Re: [ ] Breast feeding while on Gleevec Date: Sunday, October 3, 2010, 1:13 PM  I'm 28 Thanks [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 Thank u ! Sent via BlackBerry by AT & T [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > >_http://tinyurl.com/29fl97v_ (http://tinyurl.com/29fl97v) > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > >_ttp://tinyurl.com/2g82tpc_ (ttp://tinyurl.com/2g82tpc) > > FYI, > > Lottie Duthu > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > > > > > > > [Non-text portions of this message have been removed] > [Non-text portions of this message have been removed] [Non-text portions of this message have been removed] [Non-text portions of this message have been removed] Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 Thank u Sent via BlackBerry by AT & T [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 Thank u ! Sent via BlackBerry by AT & T [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 3, 2010 Report Share Posted October 3, 2010 I'm 49 and have received a massive amount of help from this group for almost 5 years. Jackie _____ From: [mailto: ] On Behalf Of Mumminki Sent: Monday, 4 October 2010 6:18 AM Subject: Re: [ ] Breast feeding while on Gleevec I'm done with this group. It should be called CML-support offered to over 60's only, no baby related subjects allowed. > > , > > I don't often post, I have trouble on with certain of my computers but I > borrowed my friend's Mac because this is not a time for silence. First let me > say that I'm sorry you feel that you don't belong in the group. Of course you > belong, you have CML. But that is in many cases the only common thread that > connects us. Yet we become friends and in many cases family. Who else can > really understand the path we walk? Friendships are formed here but even in the > greatest of friendships there may be disagreements. It appears this is one such > time. > > You are correct when you say breast feeding is good for children. You are > correct when you say, it is your decision to continue to breast feed. I think > the issue began when you stated that anyone who did not breast feed is a bad > mother. > > We have enough struggles with our disease without judging each other and to > paint us as bad mothers is hurtful. > > It appears from your post that you did your research but all the journals in > the world cannot predict the future. You say that you are young, then perhaps > you are not aware of the drugs that did not impact the mothers but did give the > daughters cancer as young women. As parents we are charged to do what is right > for our children. We make decisions everyday which hopefully are centered on > the needs of the child; not our own. > > We are lucky that CML in chronic phase is slow moving. I probably had it for > almost two years before diagnosis. While I drink green tea daily and have for > about 15 years, I think and it is just my opinion, that you were able to carry > your baby to term and remain off meds due to the slow progression which is the > hallmark of the disease in chronic phase. The story may have had a different > ending if you were in blast phase at diagnosis. I'm not arguing with you, I have > no need to be right. I just want you to consider other view points when you are > making your decisions. > > I can tell you are a loving and caring mother. I guess that this discussion is > rendered moot by your statement that you are pretty much dried up and now just > breast feed for comfort. Even as non-scientist we have to believe that something > that can affect us at a genetic level, as Gleevec does, has to be some pretty > strong stuff. You wouldn't take a spoon and feed her a little bit of poison, > even 10%. You state how much you love breast feeding, please consider whose > needs and comfort are being met, if in fact there is no nutritional value and > there may even be harm. > > I hope you will stay as a member. I'm sorry if you felt attacked but from where > I sit you lobbed the first round- with the bad mother comment. We all are > connected by our disease. But we can't leave our manners at the door. Are you > aware that we have Skip who has had CML for over 30 years? Or that many of the > people on this list were in the clinical trials for the very medicine that is > keeping you alive? We are fortunate to have a living history of the fight > against this disease. They have so much knowledge. Please stay and benefit > from this knowledge. > > One final piece of information if you were in the US, your doctor would probably > have reported you for child endangerment based on all of the warnings documented > by Novartis. > > I have no judgement on what kind of a mother you are ; I hope you will extend > the same courtesy to the rest of us - we do the best we can and when we know > better, the hope is that we will do better. I know I try to do better everyday. > > China > > > > ________________________________ > From: d'Araille <darajek@...> > <mailto:%40> > Sent: Sun, October 3, 2010 7:10:37 AM > Subject: Re: [ ] Breast feeding while on Gleevec > > > Unfortunately I'm on the same boat as any other member of this group but not on > the same page, or rather not even in the same book. > If you think it was or is easy for me to be diagnosed with cml at 22 weeks of my > last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7 months > you got it all wrong. > At least most of you have mature families with some grandchildren, something I > may not experience my self so I'm making the most of what I've got now. > The hell with it! > > > From: onthewtr@... > Sent: Saturday, October 02, 2010 10:19 PM > <mailto:%40> > Subject: Re: [ ] Breast feeding while on Gleevec > > who r u to make such a strong untrue selfish illiterate statement? That is > totally out of line! > > Sent via BlackBerry by AT & T > > [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 4, 2010 Report Share Posted October 4, 2010 I am 50 and have been here since 42, mother of 3 children, now 20 and 34. My twins were 12 when I was diagnosed and it was hard but we have all pulled through. Zavie was there when I needed him when I was first diagnosed on this group!!!!!! Penny Have to add one more thing, yes we all have opinions and this is what the group is for, but not to be hurtful to one another!!! From: _ryan.romero@..._ (mailto:ryan.romero@...)   <_ryan.romero@..._ (mailto:ryan.romero@...) > Subject: Re: [ ] Breast feeding while on Gleevec _ _ (mailto: ) Date: Sunday, October 3, 2010, 1:13 PM I'm 28 Thanks [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > _http://tinyurl.com/29fl97v_ (http://tinyurl.com/29fl97v) > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > _ttp://tinyurl.com/2g82tpc_ (ttp://tinyurl.com/2g82tpc) > > FYI, > > Lottie Duthu > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > [Non-text portions of this message have been removed] > > > > > > > > [Non-text portions of this message have been removed] > [Non-text portions of this message have been removed] [Non-text portions of this message have been removed] [Non-text portions of this message have been removed] Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 4, 2010 Report Share Posted October 4, 2010 I'm only 27 was diagnosed at 21 and joined around 5 years! Sent from my HTC on the Now Network from Sprint! ----- Reply message ----- From: onthewtr@... Date: Sun, Oct 3, 2010 6:09 pm Subject: [ ] Breast feeding while on Gleevec < > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 4, 2010 Report Share Posted October 4, 2010 , Lots of people here are trying to reach out to you. Having CML is a VERY difficult journey and it's one you will be living with for a long time. The people in this group can be a BIG help. I was diagnosed in 1998 and was in one of the early Gleevec trials. I don't normally post, but I hope you will continue to receive posts and let people here help when they can. You're going to have problems as you go on that others have already walked through. Let everyone help and remember that we're all " in the same boat, " as we say. We want to be a help and a solution, not a problem, to others. Things are hard enough for all of us, as it is. Gay Bratton San On Oct 3, 2010, at 7:42 PM, gilfish_15@... wrote: > I'm only 27 was diagnosed at 21 and joined around 5 years! > > Sent from my HTC on the Now Network from Sprint! > > ----- Reply message ----- > From: onthewtr@... > Date: Sun, Oct 3, 2010 6:09 pm > Subject: [ ] Breast feeding while on Gleevec > < > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 4, 2010 Report Share Posted October 4, 2010 Thank u Sent via BlackBerry by AT & T [ ] Breast feeding while on Gleevec < > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 4, 2010 Report Share Posted October 4, 2010 I am 52 - was dx'd at age 46. I was, and continue to be, a strong breast feeding advocate. I nursed both my children over 2.5 years each and was a member of La Leche League. I say this to put into perspective that I was totally DISMAYED to read 's aggressive and uncalled for post. I find it ironic that while she calls for the right of 'freedom of expression' for herself - no matter how hurtful - she takes offense at those that don't agree with her! I have recently joined this chat, after following Jerry's list for a long time. I have not like the tenor of some of the conversations there and sought some CML comradeship here. I think there is room to discuss anything that relates to living with CML - including pregnancy, baby issues, marriage/relationship issues et al. However, if we can't post honestly, while still remaining courteous, this chat cannot survive. - you are right, if you cannot have a little bit of empathy for how your unkind words may be read by others and edit them accordingly (and I say this as one who apparently IS a " fit mother " in your book), then you don't belong on this list. You are also right that doctors don't always know everything, BUT sometimes we must err on the side of caution. I am sorry that you are not able to comprehend the concern being expressed by the responses that have been posted, regarding your daughter's well being. I hope and pray that you are right that your daughter is not ingesting much milk with Gleevec. I hope and pray that she does not pay for your tunnel vision in some way in the future. Leah Peer Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 4, 2010 Report Share Posted October 4, 2010 I nursed all three of my kids and I am glad I did. I must confess that as the result of my reading and the support of La Leche League and other advocates, I began to think it was tantamount to child abuse to NOT do so. I would never say so aloud, but inwardly, I felt very sad when a friend would say she was opting for the bottle. Oh, do I chuckle at my self-righteousness now! Especially as there was clearly no difference in how our children developed! Taking any of the drugs we take sure complicates things. It also requires us to seek out the learned opinions of specialists in the CML world and the healthy-baby world. I can't imagine passing judgment on how anyone navigates this route. There's a world of difference between making an impassioned personal statement and lobbing an attack. The first invites people in and the second pushes them away. I've had to remind myself of this more than once! This group allows us to discuss such personal things and to feel so supported. I don't take it for granted for a minute. On Sun, Oct 3, 2010 at 9:12 AM, china neal <chimera46@...> wrote: > > > , > > I don't often post, I have trouble on with certain of my computers > but I > borrowed my friend's Mac because this is not a time for silence. First let > me > say that I'm sorry you feel that you don't belong in the group. Of course > you > belong, you have CML. But that is in many cases the only common thread that > > connects us. Yet we become friends and in many cases family. Who else can > really understand the path we walk? Friendships are formed here but even in > the > greatest of friendships there may be disagreements. It appears this is one > such > time. > > You are correct when you say breast feeding is good for children. You are > correct when you say, it is your decision to continue to breast feed. I > think > the issue began when you stated that anyone who did not breast feed is a > bad > mother. > > We have enough struggles with our disease without judging each other and to > > paint us as bad mothers is hurtful. > > It appears from your post that you did your research but all the journals > in > the world cannot predict the future. You say that you are young, then > perhaps > you are not aware of the drugs that did not impact the mothers but did give > the > daughters cancer as young women. As parents we are charged to do what is > right > for our children. We make decisions everyday which hopefully are centered > on > the needs of the child; not our own. > > We are lucky that CML in chronic phase is slow moving. I probably had it > for > almost two years before diagnosis. While I drink green tea daily and have > for > about 15 years, I think and it is just my opinion, that you were able to > carry > your baby to term and remain off meds due to the slow progression which is > the > hallmark of the disease in chronic phase. The story may have had a > different > ending if you were in blast phase at diagnosis. I'm not arguing with you, I > have > no need to be right. I just want you to consider other view points when you > are > making your decisions. > > I can tell you are a loving and caring mother. I guess that this discussion > is > rendered moot by your statement that you are pretty much dried up and now > just > breast feed for comfort. Even as non-scientist we have to believe that > something > that can affect us at a genetic level, as Gleevec does, has to be some > pretty > strong stuff. You wouldn't take a spoon and feed her a little bit of > poison, > even 10%. You state how much you love breast feeding, please consider whose > > needs and comfort are being met, if in fact there is no nutritional value > and > there may even be harm. > > I hope you will stay as a member. I'm sorry if you felt attacked but from > where > I sit you lobbed the first round- with the bad mother comment. We all are > connected by our disease. But we can't leave our manners at the door. Are > you > aware that we have Skip who has had CML for over 30 years? Or that many of > the > people on this list were in the clinical trials for the very medicine that > is > keeping you alive? We are fortunate to have a living history of the fight > against this disease. They have so much knowledge. Please stay and benefit > from this knowledge. > > One final piece of information if you were in the US, your doctor would > probably > have reported you for child endangerment based on all of the warnings > documented > by Novartis. > > I have no judgement on what kind of a mother you are ; I hope you will > extend > the same courtesy to the rest of us - we do the best we can and when we > know > better, the hope is that we will do better. I know I try to do better > everyday. > > China > > ________________________________ > > From: d'Araille <darajek@... <darajek%40go2.pl>> > <%40> > Sent: Sun, October 3, 2010 7:10:37 AM > > Subject: Re: [ ] Breast feeding while on Gleevec > > Unfortunately I'm on the same boat as any other member of this group but > not on > the same page, or rather not even in the same book. > If you think it was or is easy for me to be diagnosed with cml at 22 weeks > of my > last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7 > months > you got it all wrong. > At least most of you have mature families with some grandchildren, > something I > may not experience my self so I'm making the most of what I've got now. > The hell with it! > > > From: onthewtr@... <onthewtr%40discobay.net> > Sent: Saturday, October 02, 2010 10:19 PM > <%40> > Subject: Re: [ ] Breast feeding while on Gleevec > > who r u to make such a strong untrue selfish illiterate statement? > That is > totally out of line! > > Sent via BlackBerry by AT & T > > [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis > Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > > Internet Journal of Oncology. This article was written by Ault MS, > > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization > (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor > during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: > 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 > years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 4, 2010 Report Share Posted October 4, 2010 38 been here 3 years. Tammy From: andrea silveira [mailto:formiga101@...] Sent: Sunday, October 03, 2010 5:43 PM Subject: Re: [ ] Breast feeding while on Gleevec I am 29 and have been part of this group almost 7 years From: ryan.romero@... <mailto:ryan.romero%40callfusion.com> <ryan.romero@... <mailto:ryan.romero%40callfusion.com> > Subject: Re: [ ] Breast feeding while on Gleevec <mailto:%40> Date: Sunday, October 3, 2010, 1:13 PM I'm 28 Thanks [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 4, 2010 Report Share Posted October 4, 2010 Please remove my email from this list. Thanks. [ ] Breast feeding while on Gleevec > > I am gravely concerned about a member who posted recently that she was > breast feeding her baby while on Gleevec. I want her to know that I am not > judging her, but merely reiterating what has been passed down to us > repeately. In speaking directly to her, I hope you have permission, dear > member from your doctor or you could be playing Russian roulette with your > baby's health. This is the warning that comes with Gleevec. Women who want > to become pregnant should not do so while taking Gleevec or any other TKI. > If you need further proof, I urge you to please contact the Novartis Hotline > or the instructions that comes in your package. This comes from their > webpage: > > Who should NOT take GLEEVEC > Women who are or could be pregnant. Fetal harm can occur when administered > to pregnant women; therefore, women should not become pregnant, as well as > be advised of the potential risk to the unborn child if GLEEVEC is used > during pregnancy. > > " Women who are breast-feeding because of the potential for serious adverse > reactions in nursing infants. > > " Sexually active females should use adequate birth control while taking > GLEEVEC. > > " Be sure to talk to your doctor and/or healthcare professional about these > issues before taking GLEEVEC " > > http://tinyurl.com/29fl97v > --_________________ > > I further give you warnings from the following information published in the > Internet Journal of Oncology. This article was written by Ault MS, > RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner > School of Nursing The University of Texas Health Science Center at Houston > and I quote from her article (noted in 2010 Volume 7 Number 2). > > I have known Pat Ault for a long time, also most of the doctors in that > department. She would not have been given permission to write this article > without the blessings of the doctors at MDACC that she works under and I > respect her authority on the subject of CML. > > You will note that everything I copied is in " quotations " . Some quotes I > have excerpted are posted here, but the entire article can be seen at the > recited website listed below the quotes, however, it is very lengthy: > > " Management of CML during pregnancy poses challenges to both hematologists > and obstetricians. Currently, consensus is lacking in management of CML in > pregnancy; therefore, clinical observations have become important. Most of > these observations are derived from small case series or case reports. > > " Therefore, leukapheresis may be an intermittent short-term alternative > option for pregnant patients, and prevents fetal exposure to TERATOGENIC > drugs. However, leukapheresis is cumbersome, costly, and a time consuming > procedure, with risk of infection, thrombosis and hypotensive events that > may affect the fetus and patient. > " ........... high concentrations of imatinib are DETECTED IN BREAST MILK. > " Investigation of the placentas included standard pathologic analysis, > computer assisted morphometry, and fluorescence in situ hybridization (FISH) > analysis. This patient was treated with a targeted tyrosine inhibitor during > first trimester of a first pregnancy and during the third trimester of a > second pregnancy. The umbilical cord blood and breast milk findings were: 1) > low imatinib and metabolite concentration levels found in the umbilical > blood suggest limited placental transfer in late pregnancy, and 2) HIGH > CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST > MILK. > > " Rousselot et al (2007) reported imatinib may be discontinued in patients > who achieved a complete molecular remission for a period of at least 2 years > without evidence of disease progression. > > " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN > BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in > infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d); > considering this milk intake and the infants are unlikely to receive more > than 3 mg/d imatinib daily. This amount is far from therapeutic range, > therefore, concluding that mothers with CML could safely breast-feed the > infant. However, the effects of low-dose chronic exposure of infants to > imatinib are not known, and have not undergone long-term investigation; > THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY. > > ttp://tinyurl.com/2g82tpc > > FYI, > > Lottie Duthu > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.